Selecta Biosciences to Participate in Jefferies Virtual London Healthcare Conference
Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology firm, announced its participation in the Jefferies Virtual London Healthcare Conference on November 18-19, 2021. The company will provide a corporate update and engage in one-on-one investor meetings. The presentation is scheduled for November 18 at 8:00 a.m. GMT (3:00 a.m. EST). Interested parties can access the live webcast and subsequent archived version through Selecta's official website.
- None.
- None.
WATERTOWN, Mass., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated ImmTOR™ platform to develop tolerogenic therapies that selectively mitigate unwanted immune responses, today announced that Company’s Management will provide a corporate update and participate in one-on-one investor meetings at the Jefferies London Healthcare Conference, to be held virtually November 18-19, 2021.
Details on the conference can be found below.
Jefferies Virtual London Healthcare Conference
Format: Presentation and one-on-one investor meetings
Date: Thursday November 18, 2021
Presentation Time: 8:00 a.m. GMT / 3:00 a.m. EST
Webcast: Click Here
An archived webcast will also be accessible in the Investors & Media section of the company’s website at www.selectabio.com.
About Selecta Biosciences, Inc.
Selecta Biosciences Inc. (NASDAQ: SELB) is a clinical stage biotechnology company leveraging its ImmTOR™ platform to develop tolerogenic therapies that selectively mitigate unwanted immune responses. With a proven ability to induce tolerance to highly immunogenic proteins, ImmTOR has the potential to amplify the efficacy of biologic therapies, including redosing of life-saving gene therapies, as well as restore the body’s natural self-tolerance in autoimmune diseases. Selecta has several proprietary and partnered programs in its pipeline focused on enzyme therapies, gene therapies, and autoimmune diseases. Selecta Biosciences is headquartered in the Greater Boston area. For more information, please visit www.selectabio.com.
For Investors:
Bruce Mackle
LifeSci Advisors, LLC
+1-929-469-3859
bmackle@lifesciadvisors.com
For Media:
Brittany Leigh, Ph.D.
LifeSci Communications, LLC
+1-646-751-4366
bleigh@lifescicomms.com
FAQ
What is Selecta Biosciences presenting at the Jefferies London Healthcare Conference?
When will Selecta Biosciences' presentation take place during the Jefferies Conference?
How can I access Selecta Biosciences' presentation at the conference?
What is the significance of Selecta Biosciences' ImmTOR™ platform?
Is there a date for the Jefferies London Healthcare Conference?
